Serum adipokine levels in adults with a history of childhood maltreatment

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 37, Issue 2, 2012, Pages 217-221

  Lehto, Soili M ^a,b   Elomaa, Antti Pekka ^a,b   Niskanen, Leo ^b,c   Herzig, Karl Heinz ^d   Tolmunen, Tommi ^a,b   Viinamäki, Heimo ^a,b   Koivumaa Honkanen, Heli ^d,e   Huotari, Anne ^b   Honkalampi, Kirsi ^a,b,f   Valkonen Korhonen, Minna ^a,b   Sinikallio, Sanna ^a   Ruotsalainen, Heli ^b   Hintikka, Jukka ^a,b,g,h  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e LAPLAND CENTRAL HOSPITAL   (Finland)

^f Kuopio Psychiatric Center   (Finland)

^g PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^h TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Adiponectin; Inflammation; Maltreatment; Metabolic disturbance; Resistin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BIOLOGICAL MARKER; RESISTIN;

ADULT; ARTICLE; BODY MASS; CHILD ABUSE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MEDICAL HISTORY; METABOLIC DISORDER; PROTEIN BLOOD LEVEL; PROTEIN SECRETION;

ADIPONECTIN; ADULT; ADULT SURVIVORS OF CHILD ABUSE; AGE FACTORS; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INFLAMMATION; MALE; MENTAL HEALTH; MIDDLE AGED; QUESTIONNAIRES; RESISTIN; SEX FACTORS;

EID: 84859561941     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.01.016     Document Type: Article

References (38)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 1994, Washington, DC. fourth ed.
2. Bagby R.M., Parker J.D.A., Taylor G.J. The twenty-item Toronto Alexithymia Scale-I: item selection and cross-validation of the factor structure. J Psychosom Res 1994, 38:23-32.
3. Bagby R.M., Taylor G.J., Parker J.D.A. The twenty-item Toronto Alexithymia Scale-II: convergent, discriminant, and concurrent validity. J Psychosom Res 1994, 38:33-40.
4. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
5. Carpenter L.L., Gawuga C.E., Tyrka A.R., Lee J.K., Anderson G.M., Price L.H. Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology 2010, 35:2617-2623.
6. Charmandari E., Kino T., Souvatzoglou E., Chrousos G.P. Pediatric stress: hormonal mediators and human development. Horm Res 2003, 59:161-179.
7. Danese A., Pariante C.M., Caspi A., Taylor A., Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci USA 2007, 104:1319-1324.
8. Danese A., Moffitt T.E., Pariante C.M., Ambler A., Poulton R., Caspi A. Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry 2008, 65:409-415.
9. Danese A., Moffitt T.E., Harrington H., Milne B.J., Polanczyk G., Pariante C.M., et al. Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med 2009, 163:1135-1143.
10. de Jager W., te Velthuis H., Prakken B.J., Kuis W., Rijkers G.T. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear. Cells Clin Diagn Lab Immunol 2003, 10:133-139.
11. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010, 67:446-457.
12. Dube S.R., Cook M.L., Edwards V.J. Health-related outcomes of adverse childhood experiences in Texas, 2002. Prev Chronic Dis 2010, 7:A52.
13. Elshal M.F., McCoy J.P. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 2006, 38:317-323.
14. Expert panel on detection, evaluation and treatment of high blood cholesterols in adults: executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA 2001, 285:2486-2497. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III).
15. Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 2001, 507:14214-14216.
16. Fergusson D.M., Lynskey M.T., Horwood L.J. Childhood sexual abuse and psychiatric disorder in young adulthood: I. Prevalence of sexual abuse and factors associated with sexual abuse. J Am Acad Child Adolesc Psychiatry 1996, 35:1355-1364.
17. Gill J., Vythilingam M., Page G.G. Low cortisol, high DHEA, and high levels of stimulated TNF-alpha, and IL-6 in women with PTSD. J Trauma Stress 2008, 21:530-539.
18. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. American Heart Association; National Heart, Lung, and Blood Institute: diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005, 112:2735-2752.
19. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010, 17:332-341.
20. Han S.H., Quon M.J., Kim J.A., Koh K.K. Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 2007, 49:531-538.
21. Honkalampi K., Lehto S.M., Koivumaa-Honkanen H., Hintikka J., Niskanen L., Valkonen-Korhonen M., et al. Alexithymia and tissue inflammation. Psychother Psychosom 2011, 80:359-364.
22. Koivumaa-Honkanen H.T., Honkanen R., Viinamäki H., Heikkilä K., Kaprio J., Koskenvuo M. Self-reported life satisfaction and 20-year mortality in healthy Finnish adults. Am J Epidemiol 2000, 152:983-991.
23. Lehto S.M., Huotari A., Niskanen L., Tolmunen T., Koivumaa-Honkanen H., Honkalampi K., et al. Serum adiponectin and resistin levels in major depressive disorder. Acta Psychiatr Scand 2010, 121:209-215.
24. Lehto S.M., Niskanen L., Herzig K.-H., Tolmunen T., Huotari A., Viinamäki H., et al. Serum chemokine levels in major depressive disorder. Psychoneuroendocrinology 2010, 35:226-232.
25. Leng S.X., McElhaney J.E., Walston J.D., Xie D., Fedarko N.S., Kuchel G.A. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 2008, 63:879-884.
26. Leo R., Di Lorenzo G., Tesauro M., Cola C., Fortuna E., Zanasi M., et al. Decreased plasma adiponectin concentration in major depression. Neurosci Lett 2006, 407:211-213.
27. Liu M., Liu F. Transcriptional and post-translational regulation of adiponectin. Biochem J 2009, 425:41-52.
28. Midei A.J., Matthews K.A., Bromberger J.T. Childhood abuse is associated with adiposity in midlife women: possible pathways through trait anger and reproductive hormones. Psychosom Med 2010, 72:215-223.
29. Pace T.W., Heim C.M. A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain Behav Immun 2011, 25:6-13.
30. Pischon T., Hotamisligil G.S., Rimm E.B. Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem 2003, 49:650-652.
31. Rohde P., Ichikawa L., Simon G.E., Ludman E.J., Linde J.A., Jeffery R.W., et al. Associations of child sexual and physical abuse with obesity and depression in middle-aged women. Child Abuse Negl 2008, 32:878-887.
32. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
33. Takahashi N., Anan F., Nakagawa M., Yufu K., Shinohara T., Tsubone T., et al. Hypoadiponectinemia in type 2 diabetes mellitus in men is associated with sympathetic overactivity as evaluated by cardiac 123I-metaiodobenzylguanidine scintigraphy. Metabolism 2007, 56:919-924.
34. Tanida M., Shen J., Horii Y., Matsuda M., Kihara S., Funahashi T., et al. Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Exp Biol Med 2007, 232:390-397.
35. Tilg H., Moschen A.R. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006, 6:772-783.
36. Viinamäki H., Heiskanen T., Lehto S.M., Niskanen L., Koivumaa-Honkanen H., Tolmunen T., et al. Association of depressive symptoms and metabolic syndrome in men. Acta Psychiatr Scand 2009, 120:23-29.
37. Weber D.A., Reynolds C.R. Clinical perspectives on neurobiological effects of psychological trauma. Neuropsychol Rev 2004, 14:115-129.
38. Yudkin J.S., Juhan-Vague I., Hawe E., Humphries S.E., di Minno G., Margaglione M., et al. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 2004, 53:852-857.